N-((1S,2S)-2-Amino-1,2-diphenylethyl)methanesulfonamide
98%
- Product Code: 70214
CAS:
300345-76-0
Molecular Weight: | 290.38 g./mol | Molecular Formula: | C₁₅H₁₈N₂O₂S |
---|---|---|---|
EC Number: | MDL Number: | MFCD03791037 | |
Melting Point: | 118-120 °C | Boiling Point: | |
Density: | Storage Condition: | 2-8°C |
Product Description:
This compound is primarily utilized in the field of pharmaceutical research and development, particularly in the synthesis of chiral molecules. Its structure, featuring a diphenylethyl backbone and a methanesulfonamide group, makes it a valuable intermediate in the production of enantiomerically pure compounds. These compounds are often explored for their potential as active pharmaceutical ingredients (APIs) in drugs targeting neurological disorders, including Parkinson's disease and other conditions requiring dopaminergic modulation. Additionally, its chiral nature is leveraged in asymmetric synthesis, where it serves as a ligand or catalyst to induce stereoselectivity in chemical reactions, enhancing the efficiency and specificity of drug manufacturing processes.
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.250 | 10-20 days | ฿2,349.00 |
+
-
|
1.000 | 10-20 days | ฿7,020.00 |
+
-
|
N-((1S,2S)-2-Amino-1,2-diphenylethyl)methanesulfonamide
This compound is primarily utilized in the field of pharmaceutical research and development, particularly in the synthesis of chiral molecules. Its structure, featuring a diphenylethyl backbone and a methanesulfonamide group, makes it a valuable intermediate in the production of enantiomerically pure compounds. These compounds are often explored for their potential as active pharmaceutical ingredients (APIs) in drugs targeting neurological disorders, including Parkinson's disease and other conditions requiring dopaminergic modulation. Additionally, its chiral nature is leveraged in asymmetric synthesis, where it serves as a ligand or catalyst to induce stereoselectivity in chemical reactions, enhancing the efficiency and specificity of drug manufacturing processes.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :